Childhood Gliosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-04-08
Clinical Trial Update: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors [Phase 1]
Phase 1 trial investigating palbociclib isethionate in pediatric CNS tumors; status terminated with posted results in 2020.